Infections Fungal Infections or Candidiasis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Fungal Infections or Candidiasis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Fungal Infections or Candidiasis Projects
--AM-Pharma B.V.
--Allermed Laboratories, Inc.
--BioAlliance Pharma
--Basilea Pharmaceutica AG
--Cellegy Pharmaceuticals Inc
--Breckenridge Pharmaceutical, Inc.
--KAKEN PHARMACEUTICAL CO., LTD.
--ELPEN Pharmaceutical Co. Inc.
--Pacgen Biopharmaceuticals Corporation
--Novartis AG
--Perrigo Company
--Par Pharmaceutical Companies Inc
--Pfizer Inc
--Pfizer Canada Inc
--SpePharm Holding BV
--ProStrakan Group plc
--Stiefel Laboratories, Inc.
--SSP CO., LTD.

--Top Companies in early stage Fungal Infections or Candidiasis Projects
--CEPTYR, Inc.
--Anacor Pharmaceuticals, Inc.
--DAIICHI SANKYO COMPANY, LIMITED
--Daewoong Pharmaceutical Co. Ltd.
--iCo Therapeutics Inc.
--Helix BioMedix Inc
--MethylGene Inc
--Macrozyme B.V.
--Nektar Therapeutics
--MycoLogics, Inc
--Ranbaxy Laboratories Ltd.
--Novexel
--Spherics, Inc
--Samyang Corporation
--Taiwan Liposome Company
--Summit plc
--TOYAMA CHEMICAL CO.,LTD.
--TheraCarb Inc.
--YORK PHARMA PLC
--Vybion, Inc
--erly Viral Therapeutics, Inc.)

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View